Unity Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch UBX and buy or sell other stocks, ETFs, and their options commission-free!About UBX
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees16
Employees16
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2009
Founded2009
Employees16
Employees16
UBX Key Statistics
Market cap29.78M
Market cap29.78M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume54.60K
Average volume54.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.10
52 Week high$3.10
52 Week low$0.0487
52 Week low$0.0487
Stock Snapshot
As of today, Unity Biotechnology(UBX) shares are valued at $1.73. The company's market cap stands at 29.78M, with a P/E ratio of -0.03.
During the trading day, Unity Biotechnology(UBX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Unity Biotechnology(UBX) stock has reached 0, versus its average volume of 54.6K.
Over the past 52 weeks, Unity Biotechnology(UBX) stock has traded between a high of $3.10 and a low of $0.05.
Over the past 52 weeks, Unity Biotechnology(UBX) stock has traded between a high of $3.10 and a low of $0.05.
People also own
Based on the portfolios of people who own UBX. This list is generated using Robinhood data, and it’s not a recommendation.